ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on a Randomized Phase II/III PARTNER Trial to Evaluate the Safety & Efficacy of the Addition of Olaparib to Platinum-Based Neoadjuvant Chemo in TNBC and/or Germline BRCAm BC
By
ASCO 2022 Conference Coverage
FEATURING
Rebecca Lucey
By
ASCO 2022 Conference Coverage
FEATURING
Rebecca Lucey
119 views
June 16, 2022
Comments 0
Login to view comments.
Click here to Login
Breast